No earnings within 2 weeks of this transaction.
| Insider | Enguent Jean-Pierre |
|---|---|
| Title | Vice President, R&DSS |
| Transaction Date | Oct 5, 2026 |
| Exercise Date | Oct 5, 2026 |
| Expiration Date | Apr 30, 2032 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Employee Stock Option Plan (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Oct 7, 2026 |
| Shares Purchased | 50,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 50,000 |
| Derivative | Derivative |
| Accession Number | 0002114888-26-000017 |
| Document | View SEC Filing |